The global embolic protection devices market is estimated to record a substantial CAGR of 8.0% during the forecast period (2021-2027). Cardiovascular and neurovascular diseases are recognized as the leading cause of fatality and disability across the globe. Coronary artery disease (CAD) and peripheral artery disease (PAD) are the leading cardiovascular diseases globally. Besides, saphenous vein graft (SVG) failure is also common in patients following coronary artery bypass graft (CABG) surgery for treating CAD. In addition, about 250,000 patients have symptomatic severe AS. Such rising disease burden is influencing the higher uptake of embolic protection devices during various percutaneous cardiac procedures, including PCI, atherectomy, TAVR, CAS, to reduce the number of complications caused by debris being released into the bloodstream due to the procedures and causing blockages in smaller vessels by capturing and removing them. Therefore, the growing prevalence of various cardiovascular and neurovascular diseases are significantly contributing to the growth of the global embolic protection devices market.
(Get 15% Discount on Buying this Report)
Get Report Sample Copy @ https://www.omrglobal.com/request-sample/embolic-protection-devices-market
However, despite the success of embolic protection devices in many cardiovascular & peripheral and neurovascular applications, the clinical adoption of EPDs is still lagging compared to the expected penetration of the devices. In addition, the inadequate training of HCPs in LMICs regarding the latest surgical devices, infrastructure inadequacy, high procedural cost followed by poor reimbursement scenario are the major factors that can lead to the lesser uptake of modern embolic protection devices, which can limit the market growth.
A Full Report of Embolic Protection Devices Market is Available at: https://www.omrglobal.com/industry-reports/embolic-protection-devices-market
Market Coverage
- Market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered- by Product, Application, and End-user
- Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
- Competitive Landscape- Abbott; Boston Scientific Corp.; Cardinal Health, Inc.; and Medtronic plc
Global Embolic Protection Devices Market Report Segment
By Product
- Filter Devices
- Occlusion Devices
By Application
- Cardiovascular & Peripheral
- Neurovascular
By End-user
- Ambulatory Surgery Centers
- Freestanding CATH Labs
- Hospitals
- Specialty Cardiac Centers
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
